PT2445486T - Comprimidos de ibuprofeno de sódio e métodos de fabrico de composições farmacêuticas que incluem ibuprofeno de sódio - Google Patents

Comprimidos de ibuprofeno de sódio e métodos de fabrico de composições farmacêuticas que incluem ibuprofeno de sódio

Info

Publication number
PT2445486T
PT2445486T PT107259491T PT10725949T PT2445486T PT 2445486 T PT2445486 T PT 2445486T PT 107259491 T PT107259491 T PT 107259491T PT 10725949 T PT10725949 T PT 10725949T PT 2445486 T PT2445486 T PT 2445486T
Authority
PT
Portugal
Prior art keywords
ibupphene
sodium
pills
manufacture
methods
Prior art date
Application number
PT107259491T
Other languages
English (en)
Inventor
J Seyer Jeffery
L Conder Amy
P Taylor Angela
Rene Shaw Bonny
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PT2445486T publication Critical patent/PT2445486T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT107259491T 2009-06-22 2010-06-21 Comprimidos de ibuprofeno de sódio e métodos de fabrico de composições farmacêuticas que incluem ibuprofeno de sódio PT2445486T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21914909P 2009-06-22 2009-06-22

Publications (1)

Publication Number Publication Date
PT2445486T true PT2445486T (pt) 2018-01-03

Family

ID=42543076

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107259491T PT2445486T (pt) 2009-06-22 2010-06-21 Comprimidos de ibuprofeno de sódio e métodos de fabrico de composições farmacêuticas que incluem ibuprofeno de sódio

Country Status (21)

Country Link
US (4) US20100323005A1 (pt)
EP (1) EP2445486B1 (pt)
JP (2) JP2012530781A (pt)
KR (2) KR20140053414A (pt)
CN (2) CN102802613A (pt)
AR (1) AR077189A1 (pt)
AU (1) AU2010270976B2 (pt)
CA (1) CA2764740C (pt)
CO (1) CO6480926A2 (pt)
ES (1) ES2654331T3 (pt)
HU (1) HUE037827T2 (pt)
IL (2) IL216602B (pt)
MX (3) MX374707B (pt)
NZ (2) NZ620828A (pt)
PL (1) PL2445486T3 (pt)
PT (1) PT2445486T (pt)
RU (3) RU2011150661A (pt)
SG (2) SG10201509312UA (pt)
TW (3) TWI477270B (pt)
WO (1) WO2011005478A2 (pt)
ZA (1) ZA201109501B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
CA2987912C (en) 2015-06-30 2023-01-24 Genentech, Inc. Immediate-release tablets containing a drug and processes for forming the tablets

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476248A (en) * 1983-02-28 1984-10-09 The Upjohn Company Crystallization of ibuprofen
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US4980375A (en) * 1987-07-10 1990-12-25 Sterling Drug Inc. Onset-hastened/enhanced antipyretic response
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
US5104648A (en) * 1989-02-02 1992-04-14 Mallinckrodt Specialty Chemicals Company High ibuprofen content granulations
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
KR100198044B1 (ko) * 1991-05-13 1999-06-15 아이 에이 호틴 이부프로펜 염을 포함하는 약제학적 조성물
ATE180668T1 (de) * 1992-12-01 1999-06-15 Spirig Ag S(+)-ibuprofen enthaltende arzneimittel
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
WO1999008670A1 (en) * 1997-08-20 1999-02-25 Guglietta, Antonio Gaba analogs to prevent and treat gastrointestinal damage
CA2293605A1 (en) * 1998-04-11 1999-10-21 Paolo Luca Maria Giorgetti Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
CH693586A8 (de) * 2002-10-14 2003-12-15 Roche Consumer Health Ag Darreichungsform von Ibuprofen-Natrium.
US20080020042A1 (en) * 2003-10-14 2008-01-24 Peter Gruber Dosage form of sodium ibuprofen
WO2005121061A1 (en) * 2004-06-07 2005-12-22 Strides Research And Specialty Chemicals Limited Novel process for producing ibuprofen sodium dihydrate
WO2006016126A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising paracetamol a nsaid and a sugar alcohol made by melt extrusion
WO2008008120A1 (en) * 2006-07-14 2008-01-17 Fmc Corporation Solid form
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio

Also Published As

Publication number Publication date
KR101429331B1 (ko) 2014-08-11
IL216602A0 (en) 2012-02-29
CN104922084A (zh) 2015-09-23
RU2015122313A3 (pt) 2018-12-21
SG176221A1 (en) 2012-01-30
BRPI1010748A2 (pt) 2016-03-22
JP2012530781A (ja) 2012-12-06
EP2445486B1 (en) 2017-11-08
ES2654331T3 (es) 2018-02-13
AR077189A1 (es) 2011-08-10
RU2015122313A (ru) 2018-12-20
KR20140053414A (ko) 2014-05-07
CN104922084B (zh) 2020-01-14
NZ620828A (en) 2014-08-29
IL216602B (en) 2019-09-26
US20100323005A1 (en) 2010-12-23
JP6446413B2 (ja) 2018-12-26
US20200009093A1 (en) 2020-01-09
KR20120026559A (ko) 2012-03-19
CA2764740A1 (en) 2011-01-13
TW201521717A (zh) 2015-06-16
TWI477270B (zh) 2015-03-21
IL253975A0 (en) 2017-10-31
TWI504393B (zh) 2015-10-21
AU2010270976A1 (en) 2011-12-15
TWI542344B (zh) 2016-07-21
HK1213783A1 (zh) 2016-07-15
JP2016222696A (ja) 2016-12-28
CA2764740C (en) 2015-09-01
ZA201109501B (en) 2012-09-26
WO2011005478A3 (en) 2011-11-17
CN102802613A (zh) 2012-11-28
TW201318622A (zh) 2013-05-16
AU2010270976B2 (en) 2014-03-20
RU2019140368A (ru) 2021-06-09
HUE037827T2 (hu) 2018-09-28
MX347467B (es) 2017-04-26
RU2011150661A (ru) 2013-07-27
US20150231099A1 (en) 2015-08-20
NZ628603A (en) 2016-04-29
WO2011005478A2 (en) 2011-01-13
MX2011013912A (es) 2012-02-23
RU2715680C2 (ru) 2020-03-03
MX374707B (es) 2025-03-06
CO6480926A2 (es) 2012-07-16
PL2445486T3 (pl) 2018-04-30
TW201110964A (en) 2011-04-01
US20170319518A1 (en) 2017-11-09
SG10201509312UA (en) 2015-12-30
EP2445486A2 (en) 2012-05-02

Similar Documents

Publication Publication Date Title
CY2020008I2 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
DK2395834T3 (da) Natriumnitrit-holdige farmaceutiske sammensætninger
DK2451435T4 (da) Natriumthiosulfat-indeholdende farmaceutiske sammensætninger
DK3097925T3 (da) Farmaceutisk sammensætning
BRPI1004940A2 (pt) composição farmacêutica
BRPI1012539A2 (pt) composições farmacêuticas
EP2451274A4 (en) Pharmaceutical compositions
EP2167043A4 (en) NEW USE CO-CRYSTAL COMPOSITIONS
LT3061445T (lt) Labai koncentruotos farmacinės kompozicijos
SMT201700095B (is) Composizioni farmaceutiche per inalazione
PT2405942T (pt) Produto de administração oral
EP2229939A4 (en) CAPSULE FORMULATION
LT2966175T (lt) Farmacinės kompozicijos turinčios korteksolono-17-alfa-propionato
LT3222272T (lt) Farmacinė karbetocino kompozicija
FR2948568B1 (fr) Formulation pharmaceutique
BRPI1015939A2 (pt) composição farmacêutica
BRPI1012201A2 (pt) composto anticacerígeno e composição farmacêutica que o contém
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
IT1394400B1 (it) Composizioni farmaceutiche
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
BR112012000831A2 (pt) compostos, composições farmacêuticas e métodos relacionados
BR112012003149A2 (pt) composição farmacêutica
BR112012001340A2 (pt) composições farmacêuticas
UY33128A (es) Derivados de piridinona y composiciones farmacéuticas de los mismos
BRPI1006076A2 (pt) composicoes farmaceuticas